Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995538 · ClinicalTrials.gov registry record
Neurogenetics Patient Registry
A clinical trial of Neurogenetic Disorders, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02995538 is a study of Neurogenetic Disorders that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02995538, a study of Neurogenetic Disorders, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory testing including genetic testing (NextGen sequencing including whole exome and whole genome sequencing, SNParray, etc.), neuroradiology studies, neurophysiology studies - all ordered as clinically deemed appropriate, natural history from clinical longitudinal follow-up and to use de-identified information from this registry/ repository, when appropriate for clinical and translational research.
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-01-30 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02995538
The ClinicalTrials.gov registry entry for NCT02995538 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurogenetic Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02995538 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02995538 about?
NCT02995538 is a clinical study titled "Neurogenetics Patient Registry". The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory testing including genetic testing (NextGen sequencing including whole exome and whole genome sequencing, SNParray,...
What is the current status of trial NCT02995538?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2017-01-30. Estimated completion is 2028-01.
What conditions does trial NCT02995538 study?
This clinical trial studies the following conditions: Neurogenetic Disorders.
Who is sponsoring clinical trial NCT02995538?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02995538 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.